may be detrimental for biomechanical adaptation. [4] [5] [6] To date, no graft has successfully achieved long-term patency when used for small-diameter blood vessel (SDBV) applications. Therefore, the development of SDBV grafts has been an area of intense research focus.
Tissue-engineered blood vessels could potentially serve as an alternative source of grafts for patients. Significant progress has been made for the in vitro regeneration of SDBVs. [7] [8] [9] [10] [11] [12] L'Heureux and coworkers reported the fabrication of a completely biological human SDBV, which was produced by layering and wrapping sheets of cells around a mandrel, eliminating the use of exogenous scaffolds. 10 Such constructs exhibited burst pressures that were comparable to that of native vessels (more than 2000 mmHg). However, the long in vitro processing time is a considerable limitation of this technology. 7 Nerem and Seliktar 8 and Niklason and coworkers 9 used synthetic tubular poly(glycolic acid) (PGA) meshes to engineer SDBVs in vitro by means of a pulsatile perfusion system. The resulting constructs exhibited burst pressures higher than 2000 mmHg and desirable histological characteristics. Although these studies demonstrated the importance of mimicking in vivo mechanical conditions, PGA tubular scaffolds are not elastic and a silicone tube had to be used as a mandrel to transfer mechanical stimuli. Also, technical challenges such as relative sliding between the PGA tubular mesh and the silicone tube had to be addressed with the incorporation of Dacron sleeves. The PGA scaffold, which was initially seeded with smooth muscle cells, required long-term in vitro culture times in order to create a mechanically robust tissue equivalent before endothelial cells (ECs) could be seeded. The long-term culture time coupled with the removal of the silicone mandrel tube introduces increased risk of contamination and high costs.
Given the mechanically dynamic nature of blood vessels, scaffold mechanics are expected to be of utmost importance to the engineering of a blood vessel substitute. 13, 14 There are three major requirements for SDBV scaffolds: (1) biocompatibility and biodegradability; (2) structural similarity to the native blood vessel, 15, 16 as the scaffold should support adhesion, proliferation, and compartmentalization of smooth muscle cell (SMC) and EC functions; and (3) mechanical similarity to native blood vessels. First, ideal scaffolds should be soft and elastic. They should be able to sustain and recover from cyclic deformation without irritation to the surrounding tissues. 17, 18 Second, the compliance of the scaffolds should match the viscoelastic properties of the host vessel. 19, 20 Finally, for in vivo tissue engineering, scaffolds should be strong enough to withstand the hemodynamic forces exerted by the cardiovascular system and transfer mechanical stimulation to cells in an efficient manner in order to serve as a temporary blood conduit during tissue remodeling. 9 NOVEL BIPHASIC ELASTOMERIC SCAFFOLD With the increasing understanding of cellular and tissue reactions to vascular grafts, SDBV tissue engineering requires the development of novel scaffolds to move research closer to clinical application. In this regard, we set out to design a scaffold on the basis of the following premises: (1) an appropriate scaffold architecture should allow for simultaneous seeding of SMCs and ECs and facilitate the transfer of mechanical stimuli; (2) a cellseeded scaffold with strong mechanical strength can potentially serve as a temporary vascular graft, thereby reducing the in vitro culture time to that required to achieve an EC monolayer (in vivo tissue engineering); and (3) a compliant scaffold with an inner functional monolayer of ECs should promote long-term patency. To address the above criteria, we have been developing a family of biodegradable elastomers referred to as poly(diol citrates) to engineer an elastomeric and biodegradable scaffold for tissue engineering SDBVs. Poly(diol citrates) are easy to synthesize, potentially costeffective, and support the proliferation and differentiation of SMCs and ECs. 21, 22 In this work, we introduce a biphasic scaffold design and corresponding criteria that will be useful to vascular tissue-engineering efforts. A novel biphasic scaffold architecture was fabricated by sequential postpolymerization of concentric nonporous and porous layers of poly(diol citrates). The nonporous phase is expected to provide the following: (1) a continuous surface for EC adhesion, proliferation, and differentiation; and (2) mechanical strength and elasticity to the scaffold. The porous phase, polymerized directly onto the nonporous phase, is expected to facilitate the three-dimensional expansion and maturation of SMCs. The biphasic scaffold was evaluated via mechanical tests and cell culture experiments to assess its potential use for SDBV tissue engineering. The foreign body reaction to poly(diol citrate) scaffolds was also evaluated via subcutaneous implantation in rats.
MATERIALS AND METHODS

Poly(diol citrate) synthesis
All chemicals were purchased from Sigma-Aldrich (Milwaukee, WI). Citric acid was reacted with either C 8 or C 12 diols, creating poly(1,8-octanediol citrate) (POC) and poly(1,12-dodecanediol citrate) (PDDC). Various diols including aliphatic diols (C 6 -C 12 ), N-methyldiethanolamine (MDEA), and macrodiols such as poly(ethylene glycol) can also be used to create a polyester network with a controllable number of cross-links. Representatively, for POC synthesis, 21 equimolar amounts of citric acid and 1,8-octanediol were added to a 250-mL three-neck roundbottom flask fitted with an inlet and outlet adapter. The mixture was melted at 160-165°C under a flow of nitro-gen gas while stirring. The temperature of the system was subsequently lowered to 140°C for 30 min under stirring to create a prepolymer. The prepolymer was postpolymerized at either 60, 80, or 120°C under vacuum (2 Pa) or no vacuum for times ranging from 1 day to 2 weeks to create POC with various degrees of cross-linking.
Scaffold fabrication
Poly(diol citrate) nonporous tubes. Glass rods (ϳ3 mm in diameter) were coated with the poly(diol citrate) prepolymer solution and air dried to allow for solvent evaporation. The thickness of the tube walls was controlled by the number of coatings and the percent prepolymer in the solution. After solvent evaporation for 24 h, the prepolymer-coated glass rods were transferred into a vacuum oven for postpolymerization. The resulting solid tubes were demolded by slightly swelling the tubes in 50% ethanol-water and vacuum dried for 48 h at room temperature.
Poly(diol citrate) porous scaffolds. Prepolymer was dissolved in 1,4-dioxane to form a 25 wt% solution, followed by addition of sieved salt, which served as a porogen. The resulting slurry was cast into poly(tetrafluoroethylene) (PTFE) molds (square or tubular shapes). After solvent evaporation for 24 h, the molds were transferred into an oven for postpolymerization (80°C, 4 days). The salt in the resulting composites was leached out by successive incubations in water (produced with a Milli-Q water purification system; Millipore, Billerica, MA) every 12 h for 96 h. The resulting porous spongelike films and tubular porous scaffolds were freeze-dried for 24 h and stored in a desiccator. The porosity of porous scaffolds was controlled by adjusting the ratio of polymer to salt and measured by a method based on Archimede's principle as described elsewhere. 15 Poly(diol citrate) biphasic scaffold. For the nonporous phase, a glass rod was coated with prepolymer and partially postpolymerized at 60°C for 24 h. To create the porous phase, the coated rod was inserted concentrically in a tubular mold that contained a salt-prepolymer slurry. The prepolymer-outer mold-glass rod system was then placed in an oven for further postpolymerization. After salt leaching, the biphasic tubular scaffold was demolded from the glass rod and freeze dried (Fig. 1 ). Biphasic scaffold cross-sections were observed by SEM.
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Mechanical evaluation
Tensile tests. To investigate the effects of polymer processing on mechanical properties of scaffolds (80°C, 4 days), nonporous films, porous films (90% of porosity), and biphasic films (also referred to as scaffold) (90% porosity for porous phase) were made for tensile mechanical tests according to American Society for Testing and Materials (ASTM) 412a. The following samples were tested: POC films, PDDC films, POC porous films, PDDC porous films, biphasic scaffold with a PDDC porous phase and a PDDC nonporous phase, and biphasic scaffolds with a POC porous phase and a PDDC nonporous phase. Tests were performed on an Instron 5544 mechanical tester equipped with 500-N load cell (Instron, Norwood, MA). Briefly, dumbbell-shaped samples were pulled to failure at a rate of 500 mm/min. Ultimate tensile strength, Young's modulus, and elongation at break were obtained from stress-strain data. The thickness of porous and biphasic films was normalized to T pf ϫ (1 Ϫ porosity) and T pp ϫ (1 Ϫ porosity) ϩ T sp , respectively, where T pf is the thickness of the porous film, T pp is the thickness of the porous phase of the biphasic film, and T sp is the thickness of the nonporous (solid) phase of the biphasic film.
Compressive tests. Mechanical properties of cylindrical porous POC (120°C, 2 Pa, 1 day) scaffolds (height, 6 mm; diameter, 6 mm; porosity, 90 Ϯ 2%; pore size, 106 Ϯ 26 m) were evaluated with an Instron 5544 mechanical tester at a cross-head speed of 2 mm min Ϫ1 and a 10-N load cell. To examine the elastic recovery properties, samples were compressed to one-fifth of their original length. The compressive modulus was obtained from the initial slope of the stress-strain data. After removing the compressive force, the recovery from deformation of the samples was measured with calipers. The compressive recovery ratio was expressed as follows: through the tube while pressure and time were recorded. The process to determine burst pressure was recorded with a video camera (NTSC ZR80; Canon, Tokyo, Japan). Burst pressures of solid poly(diol citrate) tubes (inner diameter, 3.65 mm) were defined as the highest pressure value attained before failure.
Compliance measurements. Compliance was defined as the change in diameter of a sample tube during the rise in pressure between diastole and systole (typically from 80 to 120 mmHg), and was expressed as a percentage. The volume of a sample tube at 80 mmHg (V 80 ) and 120 mmHg (V 120 ) was calculated on the basis of video camera data, recorded time, flow rate, and original tube volume. Compliance was expressed as ⌬d/d (%) ϭ 0.5(V 120 /V 80 Ϫ 1) ϫ 100. 24 Foreign body reaction to implanted scaffolds POC (120°C, 2 Pa, 3 days) porous scaffolds (diameter, 7 mm; thickness, 1.5 mm; pore size, 106 Ϯ 26 m; porosity, 90 Ϯ 2%) were sterilized by exposure to ethyl-NOVEL BIPHASIC ELASTOMERIC SCAFFOLD ene oxide gas, and subcutaneously implanted in the backs of 7-week-old female Sprague-Dawley rats, using blunt dissection. Rats were under deep isoflurane-O 2 general anesthesia. The rats were killed and tissue samples (3 ϫ 3 cm) containing the implants were harvested at 7 and 30 days (three rats per time point). The samples were fixed in 10% formalin for 24 h and embedded in paraffin. Sections (5 m) were stained with hematoxylin and eosin (H&E) for histological analysis. The foreign body reaction of the POC scaffolds was compared with that of porous poly(L-lactic acid) (PLLA) scaffolds (pore size, 60-90 m; porosity, 90 Ϯ 2%; M w Ͼ 300,000; Polysciences, Warrington, PA) at 30 days.
Cell seeding and construct culture
Human aortic smooth muscle cells (HASMCs) and human aortic endothelial cells (HAECs) (Cambrex Bio Science Walkersville, Walkersville, MD) were cultured in a 50-mL culture flask with SmGM-2 and EBM-2 culture medium, respectively (Cambrex Bio Science Walkersville). Cell culture was maintained in a water-jacketed incubator (Forma Series II; Thermo Electron) equilibrated with 5% CO 2 at 37°C. Cells were not used beyond passage 5. All scaffolds for cell seeding were sterilized with ethylene oxide gas. HASMCs and HAECs were cocultured on POC biphasic scaffolds (both outer and inner phases are POC postpolymerized at 80°C, 3 days) using culture medium consisting of 3 parts SmGM-2 and 1 part EBM-2 (Cambrex Bio Science Walkersville). Briefly, one end of the scaffold was blocked and HAECs (2.6 ϫ 10 5 /mL) were seeded into the lumen of the scaffold. The EC-seeded scaffold was placed in a culture dish (60 mm in diameter) containing EBM-2 medium. One day after EC seeding, the EBM-2 medium was removed carefully with a micropipette and HASMCs, at a density of 4 ϫ 10 6 /mL, were seeded onto the porous phase. The SMC-and EC-seeded scaffold was placed in the incubator for 30 min before adding 10 mL of coculture medium. The coculture medium was changed every 2 days. Porous scaffolds (nonbiphasic) were also directly seeded with HASMCs at a density of 4 ϫ 10 6 /mL. 21 Constructs were cultured for up to 8 weeks.
SEM, histology, and immunohistochemistry
For SEM, biphasic scaffolds were fixed with 2.5% glutaraldehyde in PBS for 24 h at 4°C. After being thoroughly washed with PBS, the scaffolds were dehydrated sequentially in 50, 70, 95, and 100% ethanol, each three times (10 min each time). The fixed samples were freeze-dried, cut after freezing in liquid N 2 , sputter coated with gold, and examined under an SEM (Hitachi S-3500N ). For histology, the cell-cultured biphasic scaffolds were fixed in 10% buffered formalin (Sigma, St. Louis, MO), embedded in paraffin, sectioned into 8-to 10-m slices, and stained with hematoxylin and eosin (H&E). For immunohistochemistry, sections of the cell-seeded scaffold were deparaffinized and immunostained for the presence of the SMC-specific protein, calponin. Briefly, mouse anti-calponin (Sigma) was YANG ET AL. used at 1:10,000 dilution in blocking buffer consisting of 0.5% normal horse serum in PBS. Nonporous films seeded with ECs were fixed in 4% paraformaldehyde and immunostained for von Willebrand factor (vWF), a specific marker expressed by ECs. Rabbit anti-vWF (Santa Cruz Biotechnology, Santa Cruz, CA) was used at 1:500 dilution in 0.5% normal goat serum in PBS. Antibody-antigen complexes were visualized with a Vectastain ABC-AP kit (rabbit) for vWF and with a Vectastain Elite ABC kit (mouse) for calponin (Vector Laboratories, Burlingame, CA). Anti-mouse and anti-rabbit biotinylated secondary antibodies (diluted 1:200) were provided by the manufacturer. Calponin was visualized with a 3,3Ј-diaminobenzidine (DAB) substrate kit for peroxidase and von Willebrand factor was detected with a Vector blue substrate kit for alkaline phosphatase (Vector Laboratories).
Statistical analysis
Data were expressed as means Ϯ standard deviation. The statistical significance between two sets of data was calculated by two-tailed Student t test. Data were taken to be significant when a p value of 0.05 or less was obtained.
RESULTS
Scaffold fabrication
Despite the fact that cross-linked poly(diol citrates) are classified as thermoset polymers, in prepolymer form they can be processed into scaffolds of various shapes and porosities. 21 A novel biphasic scaffold was fabricated with biodegradable poly(diol citrate). Biphasic tubular scaffolds consisted of an inner nonporous lumen surrounded by an outer concentric porous layer (Fig. 2A) . The scaffolds were soft and could be bent repeatedly without permanent deformation or failure ( Fig. 2B and C) . The outer porous phase of the biphasic scaffold was chemically incorporated onto the nonporous phase via post- Fig. 3A and B) . Micropores (15 Ϯ 6 m) were distributed throughout the interconnected macropores and pore walls exhibited rough surfaces (Fig. 3C ).
Mechanical evaluation
POC and PDDC porous films could maintain only 8.5 and 31.1%, respectively, of tensile strength (mean value) of corresponding nonporous films (Fig. 4A ). There was a significant difference between the mechanical properties of nonporous and porous films (p Ͻ 0.05). On the other hand, PDDC-based and POC-based biphasic scaf-NOVEL BIPHASIC ELASTOMERIC SCAFFOLD folds (samples 5 and 6; see Fig. 4A ) maintained 90.2 and 70.7%, respectively, of tensile strength (mean value) relative to PDDC nonporous films. There was no statistically significant difference between the mechanical data for biphasic scaffolds and PDDC nonporous films (p Ͼ 0.05) (Fig. 4A and B) . Figure 5 shows representative stress-strain data of POC scaffolds that were subjected to compression testing. The compressive modulus of the POC scaffold was 0.152 Ϯ 0.018 MPa. The small compressive modulus and tensile Young's modulus ( diately after the release of compressive forces. Burst pressure values of poly(diol citrate) nonporous tubes (Fig.  6A) exceeded that of typical systolic pressures (ϳ120 mmHg). Burst pressure can be modulated by varying the thickness of the tube walls, postpolymerization conditions, and type of poly(diol citrate) used. Compliance of PDDC tubes (80°C; 4 days; thickness, 0.16 mm) was 12.7%, which was similar to that of dog carotid (12.7%) and human carotid (14.7%). 24 
Foreign body reaction to implanted scaffolds
After 7 days of implantation, significant fibrous tissue ingrowth occurred throughout the thickness of the scaffolds (Fig. 7A) . Porous scaffolds were loosely encapsulated with a thin (35 Ϯ 16 m) fibrous capsule. Inflammatory cells (macrophages) migrated into scaffolds from surrounding tissues and were distributed throughout the scaffolds. Many small blood vessels were found near the center of the scaffolds (Fig. 7B ) and macrophages that surrounded the copolymer fragments exhibited a rounded shape. After 30 days of implantation, the scaffolds were filled with fibrous tissue and encapsulated with a thin anisotropic fibrous matrix (Fig. 7C) . Capillary blood vessels were still present within the scaffolds and macrophages remained rounded. There was some evidence of giant cells around copolymer fragments (Fig. 7D) . No tissue necrosis was observed at either time point. The foreign body reaction was essentially similar to that of PLLA porous scaffolds that were made via the salt-leaching method and also implanted in subcutaneous pockets on the backs of rats (Fig. 7E and F) .
Cell seeding and construct culture
HASMCs seeded on porous POC stained positive for HASMC-specific calponin (brown) and surrounding collagen matrix (blue) (Fig. 8A and B) . HAECs seeded on POC nonporous films were positive for von Willebrand factor (vWF) (blue) (Fig. 8C) . Coculture of HASMCs and HAECs on biphasic scaffolds demonstrated that the biphasic scaffold design was able to compartmentalize both HASMCs and HAECs. Figure 9A shows a uniform HASMC distribution throughout the porous phase of the biphasic scaffold after 1 week in culture. HASMCs adhered to the pore walls through filopodial extensions, which are characteristic of three-dimensional attachment and proliferation, and secreted extracellular matrix (ECM) (Fig. 9C) . HAECs proliferated to confluence on the nonporous phase (Fig. 9B) .
DISCUSSION
The mechanical and microarchitectural characteristics of a blood vessel substitute are important in modulating YANG ET AL. the phenotype of vascular cells, neotissue formation, and organization. 2, 25, 26 In this article, we evaluate a novel biphasic scaffold design that takes into account scaffold mechanics (elasticity and strength) and cell compartmentalization requirements for tissue engineering a small-diameter blood vessel. An elastomeric scaffold is expected to better transmit dynamic mechanical stimuli exerted by a pulsatile bioreactor or the cardiovascular system if an in vivo tissue-engineering approach is implemented. Also, engineering the appropriate mechanics into the scaffold or blood vessel substitute should reduce compliance mismatch between the graft and host vessel, a biomechanical problem that has been cited as a factor contributing to graft failure. 6, 27, 28 Most materials commonly used as scaffolds in vascular tissue engineering [i.e., polyglycolic acid, poly(lactide-co-glycolide), and others] lack elasticity and are prone to significant permanent deformation under cyclic mechanical stimulation. 29 The few synthetic elastomeric and biodegradable materials that have been explored, that is, polycaprolactone and copolymers thereof and poly(ester urethane)ureas, 30, 31 require complex synthesis schemes that include exogenous catalysts and are not cost-effective. Therefore, in our laboratory we developed a novel class of biodegradable polyester elastomers referred to as poly(diol citrates), which address the latter concerns and can be processed into scaffolds that are suitable for vascular tissue engineering. Poly(diol citrates) are condensation copolymers based on the reaction between citric acid and 1,N-aliphatic diols (typically C 8 , C 10 , or C 12 ) or polyethylene glycols. The mechanical and biodegradation properties of poly(diol citrates) can be controlled by adjusting the feed ratio of citric acid to the chosen diol, by changing the type of diol, by adding trace amounts of cross-linking compounds such as glycerol and MDEA, or by changing postpolymerization conditions. 21, 22 Regarding the microarchitectural requirements of a scaffold for vascular tissue engineering, facilitating or recreating the cell and extracellular matrix compartmentalization found in the native vessel wall could potentially lead to a more native-like vessel 32 and also enable in vivo vascular tissue engineering. An ideal scaffold should provide the barrier function of the basement membrane for endothelial cell function and artificial elastic laminae for elasticity and separation between cell layers. We therefore set out to design and fabricate such a scaffold. The design, shown in Fig. 1 , consists of a nonporous phase or skin within the lumen of an otherwise porous tubular scaffold. Postpolymerization of the outer porous phase directly in contact with the inner nonporous phase resulted in a continuous interface between both phases of the tubular scaffold, eliminating the potential for delamination (Fig. 3A) . The porous phase of the biphasic scaffold was synthesized by particulate salt leaching and freeze-drying, which gave rise to a highly interconnec-tive porous structure with micropore features along the macropore walls (Fig. 3C) . The biphasic scaffold design would also allow rapid seeding and compartmentalization of SMCs and ECs, unlike current approaches that require long culture times for the in vitro growth and maturation of an SMC-based medial layer to enable EC seeding. 9, 33 The nonporous phase serves to mimic the barrier provided by the basement membrane for EC function and compartmentalization from SMCs. It also strengthens the porous phase and is expected to transduce mechanical stimulation to the SMCs located in the porous phase. In this respect, the biphasic scaffold had strength, modulus, and elongation values that were comparable to those of the nonporous films. The biphasic scaffold could potentially allow each cell type to receive its characteristic physiological mechanical stimulus (shear flow for ECs and circumferential and radial strain for SMCs and ECs). Therefore, the biphasic scaffold eliminates the need for a separate silicone tube to serve as a mandrel to conduct pulsatile mechanical stimuli to the surrounding porous scaffold. It also eliminates the need for "sleeves" to prevent relative sliding between the scaffold and an underlying silicone mandrel.
NOVEL BIPHASIC ELASTOMERIC SCAFFOLD
The effect of scaffold processing, that is, the incorporation of macropores, was evaluated by mechanical tests. Tensile tests performed on nonporous films, porous films, and biphasic films confirmed the utility of having a nonporous reinforcement in the lumen of a porous tube that would otherwise lose elasticity and strength because of the presence of high porosity (Fig. 4) . The nonporous phase allows tailoring of the burst pressure and compliance of the biphasic scaffold in order to meet the requirements of the replaced vessels ( Fig. 6A and B) . Thus, the biphasic scaffold could potentially be used for in vivo vascular tissue engineering by providing a strong, compliant, and biodegradable blood flow conduit that can be remodeled by cells that were seeded ex vivo. As this approach would likely require only the culture of an EC monolayer to minimize or prevent thrombosis, in vitro culture time and expenses should be significantly reduced. In other words, a fully developed, in vitro-engineered medial layer is not required. The biphasic scaffold can also be used as a model scaffold to study the effect of scaffold compliance on new tissue formation during in vitro culture. Regarding recovery from deformation, the fast and complete recovery of porous scaf- folds that were subjected to compressive forces suggests that permanent deformation should not be a significant concern.
The foreign body response to porous polydiol citrate scaffolds was comparable to that of porous PLLA scaffolds, a biodegradable polyester commonly used in tissue engineering (Fig. 7) . Although biodegradable polyesters are not used for small-diameter blood vessel replacement in the clinical setting, comparison with PLLA was a first step to gain some insight into the relative biocompatibility of poly(diol citrates). The creation of a loosely packed, vascularized capsule instead of a well-organized avascular capsule depends on the shape of macrophages that interact with the implant. Round macrophages would favor the secretion of angiogenic factors. 34, 35 The significant fibrovascular tissue ingrowth after 1 week of implantation suggests that poly(diol citrate) scaffolds may be conducive to rapid angiogenesis and adaptation to the surrounding tissue. Fibrous encapsulation of the scaffold was maintained at a minimum throughout the 1-month period, which facilitates nutrient transport to the cells within the scaffold. The presence of giant cells along the pore walls suggests that cellular degradation of the scaffolds could potentially take place and should be considered as an additional degradation mechanism. 36 Future studies will evaluate the in vivo rate of degradation of various poly(diol citrate) scaffold combinations to obtain some better insight into their application in the body. The full ingrowth of fibrovascular tissue also confirmed the interconnectivity of the scaffolds (Fig. 7C) .
The biphasic scaffold was able to compartmentalize both HASMCs and HAECs, as per the results of coculture experiments (Fig. 8) . A confluent HAEC layer (Fig.  8B) was obtained on the nonporous phase of the biphasic scaffold. Histology and immunohistochemistry results demonstrated that HASMCs and HAECs seeded on porous scaffolds and nonporous films attained a differentiated phenotype and therefore have the potential to function as a tissue unit (Fig. 9 ). In the case of endothelial cells, a functional endothelium provides a continuous thromboresistant layer between blood and the blood vessel wall. It also controls blood flow and vessel tone, platelet activation, adhesion and aggregation, leukocyte adhesion, and SMC migration and proliferation. 20 Future studies will focus on the strength of adhesion and functionality of endothelial cells on poly(diol citrates). Several techniques, including surface coating, 20 controlled surface hydrolysis, 37, 38 immobilization of biomacromolecules, [39] [40] [41] [42] and EC stress conditioning in culture, 43 have been proposed to improve cell adhesion for tissue-engineering scaffolds. Poly(diol citrate) scaffolds are amenable to all of the latter surface modification techniques to improve EC adhesion, if necessary. YANG ET AL.
In conclusion, a novel biphasic tubular scaffold consisting of connected nonporous and porous phases was fabricated and evaluated for potential use in vascular tissue engineering. The scaffold was made from poly(diol citrates), a new type of biodegradable polyester elastomer. These studies represent the first step toward the investigation of the role of scaffold mechanics in new tissue formation in vitro as well as in vivo. The biphasic scaffold could potentially be used to implement coculture of SMCs and ECs in vitro, thereby shortening culture time and reducing the risk of contamination. If the scaffold design is implemented for in vivo tissue engineering, it could potentially reduce the negative side effects associated with compliance mismatch between a graft and the host vessel, thereby improving long-term patency.
